Switch Launches with $52 Million to Advance First-of-its-Kind RNAi Technology



Comments are closed.

H2U Technologies extends series A financing and expands board of directors
QurAlis raises $42 Million Series A Financing
QurAlis Closes $88 Million Series B to Advance Precision Medicines for Neurodegenerative Diseases
QurAlis earns a spot in Fierce Biotech’s 2020 Fierce 15